BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
British Journal of Haematology, EarlyView.
Source: British Journal of Haematology - Category: Hematology Authors: Andrea Visentin
,
Silvia Imbergamo
,
Edoardo Scomazzon
,
Stefano Pravato
,
Federica Frezzato
,
Laura Bonaldi
,
Marco Pizzi
,
Stefania Vio
,
Michele Gregianin
,
Marta Burei
,
Monica Facco
,
Gianpietro Semenzato
,
Francesco Piazza
, Source Type: research
More News: Hematology | UK Health